Publication

Association Between the Chromosome 9p21 Locus and Angiographic Coronary Artery Disease Burden A Collaborative Meta-Analysis

Downloadable Content

Persistent URL
Last modified
  • 05/23/2025
Type of Material
Authors
    Kenneth Chan, Queen Mary UniversityRiyaz S. Patel, Queen Mary UniversityPaul Newcombe, MRC Biostatistics UnitChristopher P. Nelson, Glenfield HospitalAtif Qasim, University of PennsylvaniaStephen E. Epstein, Washington Hospital CenterSusan Burnett, Washington Hospital CenterViola Vaccarino, Emory UniversityA. Maziar Zafari, Emory UniversitySvati H. Shah, Duke UniversityJeffrey L. Anderson, Intermountain Medical CenterJohn F. Carlquist, Intermountain Medical CenterJaana Hartiala, Duke UniversityHooman Allayee, Duke UniversityKunihiko Hinohara, Tokyo Medical and Dental UniversityBok-Soo Lee, Sungkyunkwan UniversityAnna Erl, German Heart CenterKatrina L. Ellis, University of OtagoAnuj Goel, University of OxfordArshed Ali Quyyumi, Emory University
Language
  • English
Date
  • 2013-03-05
Publisher
  • Elsevier: 12 months
Publication Version
Copyright Statement
  • © 2013 American College of Cardiology Foundation.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0735-1097
Volume
  • 61
Issue
  • 9
Start Page
  • 957
End Page
  • 970
Grant/Funding Information
  • Complete funding list available in full text.
Abstract
  • Objectives: This study sought to ascertain the relationship of 9p21 locus with: 1) angiographic coronary artery disease (CAD) burden; and 2) myocardial infarction (MI) in individuals with underlying CAD. Background: Chromosome 9p21 variants have been robustly associated with coronary heart disease, but questions remain on the mechanism of risk, specifically whether the locus contributes to coronary atheroma burden or plaque instability. Methods: We established a collaboration of 21 studies consisting of 33,673 subjects with information on both CAD (clinical or angiographic) and MI status along with 9p21 genotype. Tabular data are provided for each cohort on the presence and burden of angiographic CAD, MI cases with underlying CAD, and the diabetic status of all subjects. Results: We first confirmed an association between 9p21 and CAD with angiographically defined cases and control subjects (pooled odds ratio [OR]: 1.31, 95% confidence interval [CI]: 1.20 to 1.43). Among subjects with angiographic CAD (n = 20,987), random-effects model identified an association with multivessel CAD, compared with those with single-vessel disease (OR: 1.10, 95% CI: 1.04 to 1.17)/copy of risk allele). Genotypic models showed an OR of 1.15, 95% CI: 1.04 to 1.26 for heterozygous carrier and OR: 1.23, 95% CI: 1.08 to 1.39 for homozygous carrier. Finally, there was no significant association between 9p21 and prevalent MI when both cases (n = 17,791) and control subjects (n = 15,882) had underlying CAD (OR: 0.99, 95% CI: 0.95 to 1.03)/risk allele. Conclusions: The 9p21 locus shows convincing association with greater burden of CAD but not with MI in the presence of underlying CAD. This adds further weight to the hypothesis that 9p21 locus primarily mediates an atherosclerotic phenotype.
Author Notes
  • Dr. Shu Ye, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University London, London, EC1M 6BQ, United Kingdom. s.ye@qmul.ac.uk.
Keywords
Research Categories
  • Health Sciences, Epidemiology
  • Biology, Genetics
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items